aapptec is a biotechnology company that specializes in the state-of-the-art peptide and organic synthesis instrumentation for use by research scientists worldwide. aapptec is a blend of strong management in both the scientific and financial fields.

aapptec’s investment group, Futurity Investment Group, LLC, has provided the resources needed to enhance and expand the current instrument line and to provide the Pharmaceutical and Biotechnology industries with new and innovative products. Futurity Investment Group has appointed Hossain Saneii, Ph.D to manage the operations of aapptec. Dr. Saneii received his first patent for an automated peptide synthesizer in the early 1980s while working at Upjohn Pharmaceutical Company in Kalamazoo, Michigan. He then started his own company in 1985 and developed all of the present aapptec patented instruments.

For the last 20 years, aapptec’s fully automated peptide synthesizers have been the most flexible and reliable instruments available in the industry. Automatic cleavage combined with the capability of doing Boc-, Fmoc- and customized chemistry protocols make it convenient for both the novice and the expert chemist. aapptec and Dr. Saneii will continue to develop and offer the research community with the latest technology for both peptide and organic synthesis.